Activation of ERK/MAPK in the lateral amygdala of the mouse is required for acquisition of a fear-potentiated startle response

Neuropsychopharmacology

Volumn 34, Issue 2, 2009, Pages 356-366

  Di Benedetto, Barbara ^a,b   Kallnik, Magdalena ^a   Weisenhorn, Daniela M Vogt ^a,b   Falls, William A ^c   Wurst, Wolfgang ^a,b   Hölter, Sabine M ^a,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF VERMONT   (United States)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Amygdala; Anxiety; ERK MAPK; Fear potentiated startle; Mouse

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONDITIONING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEAR; LATERAL AMYGDALA; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STARTLE REFLEX;

AMYGDALA; ANIMALS; BLOTTING, WESTERN; BRAIN; BUTADIENES; CONDITIONING, CLASSICAL; FEAR; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGLIA; NEURONS; NITRILES; PHOTOMICROGRAPHY; STARTLE REACTION;

EID: 57849140246     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.57     Document Type: Article

References (45)

1. Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch KP, Schmitt A (2005). The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131: 953-967.
2. Baas JM, Grillon C, Bocker KB, Brack AA, Morgan III CA, Kenemans JL et al (2002). Benzodiazepines have no effect on fear-potentiated startle in humans. Psychopharmacology (Berl) 161: 233-247.
3. Baekelandt V, Claeys A, Cherepanov P, De Clercq E, De Strooper B, Nuttin B et al (2000). DNA-dependent protein kinase is not required for efficient lentivirus integration. J Virol 74: 11278-11285.
4. Bauer EP, Schafe GE, LeDoux JE (2002). NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci 22: 5239-5249.
5. Bitsios P, Philpott A, Langley RW, Bradshaw CM, Szabadi E (1999). Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man. J Psychopharmacol 13: 226-234.
6. Blair HT, Schafe GE, Bauer EP, Rodrigues SM, LeDoux JE (2001). Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem 8: 229-242.
7. Chen CY, Shyu AB (1995). AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470.
8. Coyle JT, Duman RS (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38: 157-160.
9. Cryan JF, Holmes A (2005). The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4: 775-790.
10. Davis M (1992). The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15: 353-375.
11. Di Benedetto B, Hitz C, Holter SM, Kuhn R, Vogt Weisenhorn DM, Wurst W (2007). Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain. J Comp Neurol 500: 542-556.
12. Falls WA (2002). Fear-potentiated startle in mice. Curr Protoc Neurosci 8.11B.1-8.11B.16.
13. Falls WA, Carlson S, Turner JG, Willott JF (1997). Fear-potentiated startle in two strains of inbred mice. Behav Neurosci 111: 855-861.
14. -/- mutant mice. Behav Neurosci 114: 998-1004.
15. Ge W, Yang XJ, Zhang Z, Wang HK, Shen W, Deng QD et al (2006). Long-term potentiation of neuron-glia synapses mediated by Ca2+-permeable AMPA receptors. Science 312: 1533-1537.
16. Gegelashvili G, Schousboe A (1997). High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol 52: 6-15.
17. Grillon C, Ameli R, Goddard A, Woods SW, Davis M (1994). Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry 35: 431-439.
18. Grillon C, Ameli R, Woods SW, Merikangas K, Davis M (1991). Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex. Psychophysiology 28: 588-595.
19. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N et al (1988). The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96: 857-881.
20. Heldt S, Sundin V, Willott JF, Falls WA (2000). Posttraining lesions of the amygdala interfere with fear-potentiated startle to both visual and auditory conditioned stimuli in C57BL/6J mice. Behav Neurosci 114: 749-759.
21. Jardim MC, Nogueira RL, Graeff FG, Nunes-de-Souza RL (1999). Evaluation of the elevated T-maze as an animal model of anxiety in the mouse. Brain Res Bull 48: 407-411.
22. Kanai Y (1997). Family of neutral and acidic amino acid transporters: molecular biology, physiology and medical implications. Curr Opin Cell Biol 9: 565-572.
23. Kaufman J, Charney D (2000). Comorbidity of mood and anxiety disorders. Depress Anxiety 12(Suppl 1): 69-76.
24. LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA (1998). Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20: 937-945.
25. Mitchell P, Tollervey D (2000). mRNA stability in eukaryotes. Curr Opin Genet Dev 10: 193-198.
26. Nicholls D, Attwell D (1990). The release and uptake of excitatory amino acids. Trends Pharmacol Sci 11: 462-468.
27. Nishiyama H, Knopfel T, Endo S, Itohara S (2002). Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc Natl Acad Sci USA 99: 4037-4042.
28. Parpura V, Haydon PG (2000). Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc Natl Acad Sci USA 97: 8629-8634.
29. Paul S, Olausson P, Venkitaramani DV, Ruchkina I, Moran TD, Tronson N et al (2007). The striatal-enriched protein tyrosine phosphatase gates long-term potentiation and fear memory in the lateral amygdala. Biol Psychiatry 61: 1049-1061.
30. Paxinos G, Franklin KBJ (2001). The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: San Diego, CA, USA.
31. Phelps EA, O'Connor KJ, Gatenby JC, Gore JC, Grillon C, Davis M (2001). Activation of the left amygdala to a cognitive representation of fear. Nat Neurosci 4: 437-441.
32. Rattiner LM, Davis M, French CT, Ressler KJ (2004). Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci 24: 4796-4806.
33. Risbrough VB, Brodkin JD, Geyer MA (2003). GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology 28: 654-663.
34. Roberson ED, English JD, Adams JP, Selcher JC, Kondratick C, Sweatt JD (1999). The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci 19: 4337-4348.
35. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW et al (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686.
36. Schafe GE, Atkins CM, Swank MW, Bauer EP, Sweatt JD, LeDoux JE (2000). Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J Neurosci 20: 8177-8187.
37. Schafe GE, Nadel NV, Sullivan GM, Harris A, LeDoux JE (1999). Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem 6: 97-110.
38. Schafe GE, Nader K, Blair HT, LeDoux JE (2001). Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci 24: 540-546.
39. Seifert G, Schilling K, Steinhauser C (2006). Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 7: 194-206.
40. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K et al (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699-1702.
41. Thomas KL, Hunt SP (1993). The regional distribution of extracellularly regulated kinase-1 and -2 messenger RNA in the adult rat central nervous system. Neuroscience 56: 741-757.
42. Todd KJ, Serrano A, Lacaille JC, Robitaille R (2006). Glial cells in synaptic plasticity. J Physiol Paris 99: 75-83.
43. Valjent E, Pages C, Hervé D, Girault JA, Caboche J (2004). Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19: 1826-1836.
44. Walker DL, Davis M (2002). Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) 164: 318-328.
45. Whishaw IQ, Metz GA, Kolb B, Pellis SM (2001). Accelerated nervous system development contributes to behavioral efficiency in the laboratory mouse: a behavioral review and theoretical proposal. Dev Psychobiol 39: 151-170.